Simethicone 250 MG Chewable Tablet — RxCUI 2595235
RxNorm drug concept · Semantic clinical drug
RxCUI 2595235
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2595235
Official nameSimethicone 250 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Simethicone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Simethicone works to relieve the uncomfortable pressure, bloating, and full or stuffed feeling that comes from trapped gas in your stomach or intestines. It's used when gas builds...
- What exactly does simethicone do for gas?
- Yes — there are infant-specific simethicone products, like Mylicon Infants Gas Relief and similar infant drops, designed just for babies. They're used to relieve gas discomfort tha...
- Can I give simethicone drops to my baby?
🕸️ Concept Web — How Simethicone 250 MG Chewable Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Simethicone 250 MG Chewable Tablet
RxCUI 2595235 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Simethicone
9796IN
-
Simethicone
-
Dose forms 8
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Simethicone Chewable Tablet
373881SCDF -
Simethicone Chewable Product
1295710SCDG -
Simethicone Oral Product
1158751SCDG -
Simethicone Pill
1158752SCDG -
Chewable Tablet
91058DF -
Chewable Product
1294716DFG -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Simethicone Chewable Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Simethicone 250 MG
337310SCDC
-
Simethicone 250 MG
Showing up to 8 concepts per family — 10 of 10 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Simethicone 250 MG
SCDC · 337310 -
Simethicone Chewable Tablet
SCDF · 373881 -
Simethicone Chewable Product
SCDG · 1295710 -
Simethicone Oral Product
SCDG · 1158751 -
Simethicone Pill
SCDG · 1158752
📦 FDA Products & Package NDCs
2 products · 3 package NDCs
3 package NDCs map to RxCUI 2595235 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 51316-0702-08 | 20 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (51316-702-08) | Gas Relief SIMETHICONE 250 mg Anti-gas | CVS Pharmacy, Inc. | 2022-03-08 |
| 51316-0702-12 | 30 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (51316-702-12) | Gas Relief SIMETHICONE 250 mg Anti-gas | CVS Pharmacy, Inc. | 2024-07-17 |
| 71594-0711-15 | 48 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (71594-711-15) | Firstcare Gas Relief Simethicone 250 mg Anti-gas | USpharma Ltd | 2026-05-12 |
Observed labelers:
CVS Pharmacy, Inc. (2) ·
USpharma Ltd (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.